Immunic Newsroom

B.Riley Financial Maintains Immunic(IMUX.US) With Buy Rating, Maintains Target Price $6

Moomoo NewsNov 26 01:32 ET

Immunic's Promising Pipeline Progress and Stable Financials Justify Buy Rating

TipRanksNov 26 01:08 ET

Immunic Price Target Announced at $10.00/Share by HC Wainwright & Co.

Dow JonesNov 25 08:35 ET

Immunic Analyst Ratings

BenzingaNov 25 08:25 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Adaptimmune Therapeutics (ADAP), Fulcrum Therapeutics (FULC) and Immunic (IMUX)

TipRanksNov 19 02:26 ET

Optimistic Buy Rating for Immunic Driven by Promising Trials and Market Opportunities for VidoCa

TipRanksNov 11 01:31 ET

Immunic Analyst Ratings

BenzingaNov 7 08:35 ET

Immunic Analyst Ratings

BenzingaOct 22 07:47 ET

Immunic Stock's Popularity Rises With Consistent Buy Ratings From Analysts

TipRanksOct 21 07:27 ET

Brookline Capital Maintains Immunic(IMUX.US) With Buy Rating, Raises Target Price to $13

Moomoo NewsOct 17 07:37 ET

Analysts Are Bullish on Top Healthcare Stocks: Bluebird Bio (BLUE), Immunic (IMUX)

TipRanksSep 25 05:07 ET

B.Riley Financial Maintains Immunic(IMUX.US) With Buy Rating, Maintains Target Price $6

Moomoo NewsSep 23 22:31 ET

B.Riley Financial Maintains Immunic(IMUX.US) With Buy Rating, Maintains Target Price $6

Moomoo NewsSep 17 01:32 ET

Buy Rating Affirmed for Immunic, Inc. on Promising MS Drug Developments and Favorable Market Position

TipRanksSep 17 01:18 ET

Immunic Price Target Announced at $17.00/Share by EF Hutton

Dow JonesSep 16 08:36 ET

Immunic Initiated at Buy by EF Hutton

Dow JonesSep 16 08:36 ET

Immunic Analyst Ratings

BenzingaSep 16 08:25 ET

Leerink Partners Initiates Immunic(IMUX.US) With Buy Rating, Announces Target Price $5

Moomoo NewsSep 9 06:33 ET

Piper Sandler Sticks to Their Buy Rating for Immunic (IMUX)

TipRanksSep 4 06:59 ET

Immunic Initiated at Buy by B. Riley Securities

Dow JonesAug 27 06:23 ET